AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2025
May 14, 2025
31708_dirs_2025-05-14_1e91d0c4-cbba-4890-b644-82612e98a7db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-05-12
Reporting Person: Ross Bridget A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-12 | Common Stock | M | 3750 | $30 | Acquired | 6666 | Direct |
| 2025-05-12 | Common Stock | S | 3750 | $83.20 | Disposed | 2916 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-12 | Stock Option (Right to Buy) | $30 | M | 3750 | Disposed | 2025-04-28 | Common Stock (3750) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $83.20 to $83.21. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3: This option is fully vested and exercisable.